未分類

Our company was interviewed and introduced by “JSTORIES”, a bilingual media that introduces new innovations by Japanese companies to the world.Entitled, From lethal poison to […]

Veneno Technologies will participate in the 11th DSANJ (Drug Seeds Alliance Network Japan) Digital Bio Conference 2023 hosted by AMED, Japan Pharmaceutical Manufacturers Association, and […]

Veneno Technologies will participate in Kansai Bio Business Matching 2022. On the day of the event, Dr. Matsukawa, Director, will make a pitch introducing our […]

Veneno Technologies will participate in the 13th annual meeting of Conference on Biomolecular Screenology (Funabori, Tokyo). Dr. Taira, Director, will give a poster presentation at […]

Veneno Technologies will participate in BIO-Europoe 2022 (Online), one of Europe’s largest business matching events in the biotechnology field (drug discovery, drug discovery support, regenerative […]

Veneno Technologies will participate in BRAVE GLOBAL, an overseas networking and global expansion event hosted by Beyond Next Venture (OIST, Okinawa, Japan).

Veneno T echnologies will participate in the 17th Annual Peptide Therapeutics Symposium (Salk Institute, San Diego). Dr. Taira, Director, will give a poster presentation at […]

Veneno Technologies will exhibit at JHCVS hosted by the Ministry of Health, Labor and Welfare, which will be held in conjunction with BioJapan at Pacifico […]

Veneno Technologies published a technical article in the August issue of the scientific journal AgreBio, entitled “Veneno Suite,” the Most Advanced Disulfide Rich Peptide Screening […]

Veneno Technologies will exhibit at the 2022 BIO International Convention in San Diego as a company selected for the JETRO Overseas Operations Support Program.